Overcoming Key Challenges In Vaccine Development
Source: Cytiva
Dr. Ian Villamagna, field application scientist, Precision NanoSystems Inc., presents an overview of vaccine development and how to overcome some key challenges. Review nucleic acid vaccines verses conventional vaccine technologies.
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.
Subscribe to Biosimilar Development
X
Subscribe to Biosimilar Development
Cytiva
This website uses cookies to ensure you get the best experience on our website. Learn more